Skip to content

Efficacy of HFNC Versus NIV for Prevent Reintubation in Sepsis Patients

Efficacy of High Flow Oxygen Nasal Cannula Versus Noninvasive Positive Pressure Ventilation After Extubation in Sepsis Patients

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03246893
Enrollment
222
Registered
2017-08-11
Start date
2017-05-01
Completion date
2019-10-31
Last updated
2021-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Post Extubation Respiratory Failure, Re-intubation, Septic Shock, Severe Sepsis

Keywords

Sepsis, Septic shock, Severe sepsis, Extubation, Reintubation, Noninvasive positive pressure ventilation, High flow oxygen nasal cannula

Brief summary

Post extubation respiratory failure occur in 30% of extubated patients. More than 50% of them required reintubation. Noninvasive positive pressure ventilation (NIV) had been reported as an effective tool to prevent post extubation respiratory failure. Recently, high flow oxygen nasal cannula (HFNC) had been successfully used to prevent post extubation respiratory failure and prevent reintubation in comparable with NIV among post cardiothoracic surgery and high risk for reintubated patients. There was no information about HFNC versus NIV in prevention of reintubation among severe sepsis or septic shock patients.

Detailed description

Post extubation respiratory failure occur in 30% of extubated patients. More than 50% of them required reintubation. Noninvasive positive pressure ventilation (NIV) had been reported as an effective tool to prevent post extubation respiratory failure. Recently, high flow oxygen nasal cannula (HFNC) had been successfully used to prevent post extubation respiratory failure and prevent reintubation. The results from recent randomized controlled trials, comparing HFNC with NIV for prevent post extubation respiratory failure among post cardiac surgery and high risk patients, showed no significant different in the treatment outcome.comparable with NIV among post cardiothoracic surgery and high risk for reintubated patients. About 40-85% of severe sepsis/septic shock patients developed acute respiratory failure, required endotracheal intubation. According to the nature of patients population, usually eldery, multiple co-morbid condition and high APACHE II score, sepsis patients were considerred as high risk for reintubation, after extubated. There was no information about HFNC versus NIV in prevention of reintubation among severe sepsis or septic shock patients.

Interventions

Noninvasive positive pressure ventilation will apply via a face mask with initial setting as the following: Inspiratory pressure 6-8 cmH2O Expiratory pressure 3-5 cmH2O FiO2 30-60% Respiratory rate 12-16 per min

High flow oxygen nasal cannula will apply to patient via a nasal cannula with initial setting as the following: Temperature 37 degree celsius Flow 30 liter per min FiO2 40-60%

Sponsors

Mahidol University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Diagnosis of sepsis or septic shock according to the Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3) * Depended on mechanical ventilator for more than 48 hours * Plan for extubation due to successful weaning

Exclusion criteria

* Patient with tracheostomy * Recent upper abdominal surgery * Wound at face that prohibit face-mask application * Patient or 1st degree relative not agree to participate trial * Physician prefer either NIV or HFNC for the patient

Design outcomes

Primary

MeasureTime frameDescription
Device failure ratean average of 1 yearDevice failure to prevent reintubation, patient discomfort, change to another device within 72 hours after extubation

Secondary

MeasureTime frameDescription
Reintubation ratean average of 1 yearPatient develope respiratory failure, requiring reintubation within 72 hours after extubation
28 day mortality rateUpto 28 daysProportion of dead patients to overall patients
Hospital mortality ratean average of 1 yearProportion of dead patients to overall patients from extubation to discharge date

Countries

Thailand

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 21, 2026